Anthropic IPO Bankers Weigh Pricing Above the $70–$78 Range — $1.5 Trillion Valuation in Sight
Anthropic's bankers expect its blockbuster initial public offering to price above the $70–$78 per share range set out in its filing, after strong demand on the first day of its investor roadshow. If they are right, the AI lab's valuation could rise past $1.5 trillion — and the total amount raised could pass $100 billion. The catch, and it matters: the above-range pricing is reported, not filed. No new price range has been submitted to the SEC.
The filing itself, lodged on 10 November 2026, already made this one of the largest flotations in history. What the Financial Times reported late that same day — citing five people familiar with the deal — is that demand is strong enough for the bankers to aim higher still. This article separates what Anthropic filed from what its bankers are said to be weighing, because the gap between the two is the story.
What Anthropic actually filed
Anthropic's amended filing, known as the S-1/A, set a price range of $70–$78 per share for 825 million Class A shares. At that range the offering raises $57.75 billion to $64.35 billion. Underwriters have an option to buy a further 123.75 million shares, which would take the total raised to as much as $74 billion. On top of that sits a $26 billion concurrent private placement, running alongside the public offering.
Valuation depends on which share count you use, and the two bases give very different answers. At $78 a share, Anthropic's equity value is about $1.02 trillion on shares outstanding. On a fully diluted basis — counting shares that could be issued under options, warrants and other instruments — the figure is roughly $1.26 trillion to $1.41 trillion, with CNBC calculating up to about $1.405 trillion. When you see a valuation number for this IPO, check which basis it uses; the gap between the two is hundreds of billions of dollars.
One figure that circulated early and should not be used: a draft sent to banks late on Monday showed about 867 million shares at $70–$80, implying roughly $69.3 billion. Anthropic said those pricing details were inaccurate, and the filed terms supersede them. The $69.3 billion number is retracted, and it does not appear in this article's figures.
 |
| Traders at desks on a stock exchange floor watching monitors with rising green charts under large market ticker boards |
What the bankers are now weighing
The Financial Times reported late on 10 November, citing five people, that Anthropic's bankers expect to price the IPO above the $70–$78 range after strong first-day demand, lifting the valuation target to $1.5 trillion or more on a fully diluted basis. That implies a price of roughly $83 a share. The total raised, including the private placement and the underwriters' option, could pass $100 billion.
To be clear about the status of those numbers: they are what bankers are reported to expect, based on demand seen so far. They are not filed terms, and they can move. A book that is covered on day one can still soften, and pricing is not expected until 18 November. What the FT report does establish is the direction of travel — demand at the filed range is strong enough that the bankers are talking about more, not less.
| Measure | Filed terms (S-1/A, 10 Nov) | Reported above-range expectation (FT) |
|---|---|---|
| Price per share | $70–$78 | Above $78; ~$83 implied |
| Shares offered | 825 million Class A | Unchanged in reporting |
| Amount raised (public offering) | $57.75–$64.35bn | Could pass $100bn including private placement and greenshoe |
| Valuation, fully diluted | ~$1.26–$1.41tn | $1.5tn or more |
| Concurrent private placement | $26bn | Unchanged in reporting |
Pricing and trading dates
Pricing is expected on 18 November, with trading on the Nasdaq expected to begin on 19 November under the ticker ANT, according to CNBC, citing people familiar with the matter. Those dates are expectations, not filings, and the listing timetable can still shift — but the market is now working to them.
The demand behind the FT report is described in concrete terms. The book was already covered at the filed range on an allocable basis, meaning orders from investors who could actually be allocated shares were enough to fill the deal. CNBC reported that institutional demand was stronger than SpaceX's at the same stage of its own process — a comparison that tells you how this deal is being sized inside the market, even though the two companies are very different businesses.
What the revenue numbers say
The demand has a foundation in Anthropic's filed financials. Run-rate revenue — the annualised pace implied by recent months, not a full year of sales — stood at about $81 billion on 31 October, up $10 billion in a single month. Revenue in the third quarter of 2026 was about $17 billion. Those are the numbers the roadshow is selling: a company growing fast enough that its run rate rose by a tenth in four weeks.
For scale, a private funding round in May valued Anthropic at $965 billion. The filed range already lifts that to roughly $1.26 trillion to $1.41 trillion fully diluted; the reported above-range pricing would take it past $1.5 trillion. That is a rise of more than half in six months, driven by revenue growth rather than a re-rating alone.
Anthropic's rise also frames the rivalry at the top of the AI industry. Our flagship AI model comparison sets Claude against its rivals, and the company's work now extends well beyond chatbots — including Claude's role in AI drug discovery, the kind of applied work that institutional investors weigh alongside raw revenue growth.
 |
| The New York Stock Exchange building lit up at dusk with American flags and pedestrians on the street |
What could still change
Three things can still move this deal. First, the price itself: above-range pricing is an expectation, and the final price is set on 18 November. Second, the market: the IPO lands in the same week as Nvidia's leadership shock and a sharp slide in AI stocks, and a weak week for the sector can cool even a covered book. Third, the valuation question that shadows every AI flotation — whether the growth justifies the price — which our earlier examination of whether the AI bubble is bursting explored in detail.
The filing also leaves the mechanics in view. The underwriters' option for 123.75 million extra shares and the $26 billion private placement are both part of the deal's size, and the fully diluted valuation basis is the one to watch if the price does move above $78 — because that is the basis on which the $1.5 trillion figure is calculated.
For readers following the IPO itself, the background is in our report on the Anthropic IPO filing, which covered the original S-1 terms. This article updates that story with the filed range and the reported above-range expectations.
 |
| A man works on a laptop showing a generic AI assistant chat summarising a marketing report, with a coffee cup on the desk |
Key Takeaways
- Anthropic filed a $70–$78 range for 825 million shares, raising $57.75–$64.35 billion — up to $74 billion with the underwriters' option — plus a $26 billion private placement.
- The FT reported (late 10 Nov, citing five people) that bankers expect to price ABOVE the range after strong first-day demand, lifting the valuation target to $1.5 trillion or more, fully diluted (~$83 a share implied).
- Above-range pricing is REPORTED, not filed — no new range has been submitted to the SEC, and the final price is set on 18 November.
- At $78, equity value is ~$1.02 trillion on shares outstanding and ~$1.26–$1.41 trillion fully diluted; the two bases must not be confused.
- Trading is expected on Nasdaq on 19 November under ticker ANT; the book was already covered at the range, with institutional demand stronger than SpaceX at the same stage.
- Run-rate revenue was ~$81 billion on 31 October, up $10 billion in a month; Q3 revenue was ~$17 billion. The retracted $69.3 billion figure is not used.
Conclusion
Anthropic's IPO was already historic at the filed range. If the bankers' reported expectations hold and the deal prices above $78, it becomes something larger still: a $1.5 trillion-plus valuation and a raise that could pass $100 billion, for a company whose run-rate revenue rose $10 billion in a month. The numbers to watch are now fixed in the calendar — pricing on 18 November, trading on 19 November under the ticker ANT. Until the price is actually set, the above-range talk is a signal of demand, not a done deal — but it is a very loud signal.
Comments
Post a Comment